Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1995
11/28/1995US5470826 Single chain proteins with FHS suppressing activity isolated from follicular fluid and uses thereof
11/28/1995US5470825 Basophil granule proteins
11/28/1995US5470824 Method to treat Kaposi's sarcoma
11/28/1995US5470738 Diagnostic systems for assaying platelets in a vascular fluid
11/28/1995US5470734 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
11/28/1995US5470720 HIV antibody assays comprising p24-gp41 chimeric antigens
11/28/1995US5470571 Nomoclonal antibody
11/28/1995US5470570 Removal of viruses, proteins and microorganisms from circulatory system, HIV treatment
11/28/1995US5470569 Genetic engineering
11/28/1995CA2150334A1 L-lysyl-glycyl-l-histidine and therapeutic agent for wound healing containing the same
11/28/1995CA2150327A1 Pharmaceutical preparation for the prevention and treatment of blood coagulation disorders
11/28/1995CA1337670C Cell growth inhibitory substance
11/28/1995CA1337645C Teicoplanin-like derivatives
11/28/1995CA1337642C Neutrophil chemotactic factor, cloned cdna and monoclonal antibodies thereto
11/23/1995WO1995031566A1 Compositions and methods for targeting gene delivery vehicles
11/23/1995WO1995031565A1 Alphavirus expression vector
11/23/1995WO1995031560A1 Dna construct for effecting homologous recombination and uses thereof
11/23/1995WO1995031559A2 Methods of inducing gene expression by ionizing radiation
11/23/1995WO1995031555A1 Fusion glycoprotein from hcmv and hsv
11/23/1995WO1995031552A2 Human papilloma virus inhibition by a hairpin ribozyme
11/23/1995WO1995031551A1 Novel enzymatic rna molecules
11/23/1995WO1995031550A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins
11/23/1995WO1995031549A1 Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection
11/23/1995WO1995031546A1 Recombinant human anti-varicella zoster virus antibodies
11/23/1995WO1995031545A2 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
11/23/1995WO1995031544A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995WO1995031543A1 Dna encoding the beta subunit of a mammalian 'maxi-k' potassium channel
11/23/1995WO1995031542A1 Mutant human insulin receptor dna
11/23/1995WO1995031541A2 Methods and compositions for treatment of restenosis and cancer using ribozymes
11/23/1995WO1995031539A1 Neurotransmitter transporter
11/23/1995WO1995031538A1 Human dna topoisomerase i-alpha
11/23/1995WO1995031537A1 HUMAN OXALYL-CoA DECARBOXYLASE
11/23/1995WO1995031536A1 Process for producing thrombin
11/23/1995WO1995031532A1 Papillomavirus vaccines
11/23/1995WO1995031483A1 Improvements in or relating to peptide delivery
11/23/1995WO1995031482A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/23/1995WO1995031479A1 Methods and compositions for the dry powder formulation of interferons
11/23/1995WO1995031477A1 Vectors with multiple hiv-1 tar sequences inhibiting hiv-1 gene expression
11/23/1995WO1995031475A1 Inhibition of liver cancer by the use of gnrh and gnrh analogs
11/23/1995WO1995031474A1 Compounds for reversing drug resistance
11/23/1995WO1995031472A1 Chimeric mhc class i antigens for inducing allograft tolerance
11/23/1995WO1995031468A1 Macrophage migration inhibitory factor-3
11/23/1995WO1995031467A1 Monocyte chemotactic protein-4
11/23/1995WO1995031429A1 Photocleavable agents and conjugates for the detection and isolation of biomolecules
11/23/1995WO1995031221A1 Somatostatin binding peptide-metal chelate conjugates
11/23/1995WO1995031215A1 VACCINE FOR $i(MORAXELLA CATARRHALIS)
11/23/1995WO1995031214A1 Treatment of diabetes
11/23/1995WO1995031213A1 IFN-β LIQUID FORMULATIONS
11/23/1995WO1995031212A1 Human cd7 related compositions and methods of using the same
11/23/1995WO1995031211A1 Lacrimal gland specific emulsions for topical application to ocular tissue
11/23/1995WO1995031210A1 Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (elam-1)
11/23/1995WO1995031207A1 Antithrombin agents in treatment of asthma
11/23/1995WO1995031206A1 P75 tnf receptor promoters
11/23/1995WO1995031196A1 Method of treatment for eiph in racing stock
11/23/1995WO1995031107A1 Immunotherapeutic strategies for the treatment of cancer
11/23/1995WO1995031105A1 A method of inducing an immune response using vaccinia virus recombinants
11/23/1995WO1995029236A3 Lymphocyte activation antigens and antibodies thereto
11/23/1995WO1995028957A3 Methods for inducing t cell tolerance to a tissue or organ graft
11/23/1995WO1995026981A3 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same
11/23/1995WO1994013701A3 Delta-like gene expressed in neuroendocrine tumors
11/23/1995DE4417865A1 Two component tumour therapy using necrosis inducing agent
11/23/1995CA2490080A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995CA2190576A1 Chimeric mhc class i antigens for inducing allograft tolerance
11/23/1995CA2190529A1 Fusion glycoprotein from hcmv and hsv
11/23/1995CA2190513A1 Methods and compositions for treatment of restenosis and cancer using ribozymes
11/23/1995CA2190502A1 Methods and compositions for the dry powder formulation of interferons
11/23/1995CA2190466A1 Monocyte chemotactic protein-4
11/23/1995CA2190465A1 Ifn-.beta. liquid formulations
11/23/1995CA2190454A1 Process for producing thrombin
11/23/1995CA2190375A1 Vectors with multiple hiv-1 tar sequences inhibiting hiv-1 gene expression
11/23/1995CA2190289A1 Dna construct for effecting homologous recombination and uses thereof
11/23/1995CA2190262A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/23/1995CA2190161A1 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
11/23/1995CA2190120A1 Mutant human insulin receptor dna
11/23/1995CA2190112A1 Treatment of diabetes
11/23/1995CA2190102A1 Human papilloma virus inhibition by a hairpin ribozyme
11/23/1995CA2190101A1 Improvements in or relating to peptide delivery
11/23/1995CA2189983A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995CA2189978A1 Compounds for reversing drug resistance
11/23/1995CA2189761A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel
11/23/1995CA2189326A1 Inhibition of liver cancer by the use of gnrh and gnrh analogs
11/23/1995CA2188421A1 Alphavirus expression vector
11/23/1995CA2186615A1 Novel enzymatic rna molecules
11/23/1995CA2158926A1 Compositions and methods for targeting gene delivery vehicles
11/22/1995EP0683234A1 ANTIBODY AGAINST $g(b)-AMYLOID OR DERIVATIVE THEREOF AND USE THEREOF
11/22/1995EP0683173A1 Cyclic adhesion inhibitors
11/22/1995EP0682950A1 Mucosal administration of pneumococcal antigens
11/22/1995EP0682949A1 Virus inactivated antithrombin-III preparation free from pyrogen and thermally denatured protein
11/22/1995EP0682944A1 Stable lyophilized formulation containing a protein and dosage kit
11/22/1995EP0682873A1 Proteinhydrolysate from marine animals, process for obtaining and applications
11/22/1995EP0682714A1 Novel neutrophil inhibitors
11/22/1995EP0682712A1 Human interferon expression vectors for treating aids
11/22/1995EP0682708A1 Antiviral composition of viral protein trans-dominant variants
11/22/1995EP0682707A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
11/22/1995EP0682706A1 Novel compounds
11/22/1995EP0682705A1 Tnf-alpha muteins and a process for preparing them
11/22/1995EP0682704A1 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide
11/22/1995EP0682703A1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS
11/22/1995EP0682702A1 Expression of protective antigens
11/22/1995EP0682701A1 APOLIPOPROTEIN B mRNA EDITING PROTEIN COMPOSITIONS AND METHODS
1 ... 2816 2817 2818 2819 2820 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 ... 3163